STI tests boost HIV prevention in pregnant women
NCT ID NCT06919614
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in Botswana tests whether offering sexually transmitted infection (STI) testing alongside HIV prevention medication (PrEP) helps more pregnant women start and continue using PrEP. About 600 pregnant women without HIV will be split into two groups: one gets standard care, the other gets STI testing for chlamydia, gonorrhea, and trichomonas during pregnancy and after birth. The goal is to see if STI testing encourages better PrEP use and reduces infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DHMT Clinics
RECRUITINGGaborone, Botswana
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a class tame pregnancy stress at the genetic level?
- A nationwide test: do home visits build healthier families?
- Can a simple calcium tablet help prevent postpartum bleeding?
- Can AI read ultrasound sweeps to tell Baby's position?
- Could a smart ring unlock secrets of pregnancy health?
- Could Video-Led pelvic exercises redefine prenatal care?